IP Library Granted Patent US 10,266,831
Granted Patent B2
US 10,266,831 · App. 15/376,489 · Granted Apr 23, 2019

Recombinant microorganisms having a methanol elongation cycle (MEC)

Inventors: James C. Liao (Los Angeles, CA); Igor Bogorad (Tarzana, CA)
Assignee: The Regents of the University of California
C12N15/52C12N9/88C12N15/63C12N15/70C12P9/00C12Y401/02009C12Y401/02022Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,266,831
App. No.
15/376,489
Granted
Apr 23, 2019
Kind
B2
Abstract

Provided are microorganisms that catalyze the synthesis of chemicals and biochemicals from a methanol, methane and/or formaldehyde. Also provided are methods of generating such organisms and methods of synthesizing chemicals and biochemicals using such organisms.

Claims (10)

1. A recombinant prokaryote or yeast microorganism comprising a metabolic pathway for the synthesis of acetyl phosphate from methanol, methane or formaldehyde, wherein the microorganism is engineered to express the following enzymes: (a) a phosphoketolase (F/Xpk); (b) a transaldolase (Tal); (c) a transketolase (Tkt); (d) a ribose-5-phosphate isomerase (Rpi); (e) a ribulose-5-phosphate epimerase (Rpe); (f) a methanol dehydrogenase (Mdh); (g) a hexulose-6-phosphate synthase (Hps); (h) a hexulose-6-phosphate isomerase (Phi); (i) a dihydroxyacetone synthase (Das); and (j) a fructose-6-phosphate aldolase (Fsa), wherein at least one enzyme is heterologous to the microorganism, and wherein said microorganism has an acetyl-phosphate yield better than a wild-type or parental organism lacking Fpk and/or Xpk.

2. The recombinant microorganism of claim 1 , wherein the microorganism is derived from an E. coli microorganism.

3. The recombinant microorganism of claim 1 , wherein the microorganism is further engineered to express a phosphotransacetylase.

4. The recombinant microorganism of claim 1 , wherein the phosphoketolase comprises a sequence that is at least 49% identical to SEQ ID NO:2 and has phosphoketolase activity.

5. The recombinant microorganism of claim 1 , wherein the microorganism is E. coli comprising a genotype mdh, hps, phi and f/xpk.

6. The recombinant microorganism of claim 1 , wherein the pathway produces acetyl phosphate through carbon rearrangement of erythrose-4-phosphate (E4P) and/or glyceraldehyde-3-phosphate (G3P) and metabolism of a carbon source selected from methane, methanol, or formaldehyde.

7. The recombinant microorganism of claim 6 , wherein the microorganism is derived from an E. coli microorganism.

8. The recombinant microorganism of claim 7 , wherein the E. coli is engineered to express an Fpk, Xpk or a bifunctional F/Xpk phosphoketolase.

9. The recombinant microorganism of claim 8 , wherein the microorganism is further engineered to express a phosphotransacetylase.

10. The recombinant microorganism of claim 8 , wherein the phosphoketolase comprises a sequence that is at least 49% identical to SEQ ID NO:2 and has phosphoketolase activity.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 22, 2019
From: UNIVERSITY OF CALIFORNIA, LOS ANGELES
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 049819/0366 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2018
From: LIAO, JAMES C.; BOGORAD, IGOR
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 047525/0206 →
Continuity (3)
Continuation 14211415 · Mar 14, 2014
Provisional Application 61785143 · Mar 14, 2013
Related Publication 20170166902A1 · Jun 15, 2017